April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
HLA-DR2 and DRB1*1501 Antigens in Japanese Patients With Superior Limbic Keratoconjunctivitis
Author Affiliations & Notes
  • Y. Tagawa
    Dept of Ophthalmology and Visual Sciences, Hokkaido University Graduate Sch of Med, Sapporo-shi, Japan
  • Y. Takemoto
    Dept of Ophthalmology and Visual Sciences, Hokkaido University Graduate Sch of Med, Sapporo-shi, Japan
  • H. Nishibori
    Dept of Ophthalmology and Visual Sciences, Hokkaido University Graduate Sch of Med, Sapporo-shi, Japan
  • T. Ariga
    Dept of Ophthalmology and Visual Sciences, Hokkaido University Graduate Sch of Med, Sapporo-shi, Japan
  • Footnotes
    Commercial Relationships  Y. Tagawa, None; Y. Takemoto, None; H. Nishibori, None; T. Ariga, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 301. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Tagawa, Y. Takemoto, H. Nishibori, T. Ariga; HLA-DR2 and DRB1*1501 Antigens in Japanese Patients With Superior Limbic Keratoconjunctivitis. Invest. Ophthalmol. Vis. Sci. 2009;50(13):301.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To elucidate the genetic background of superior limbic keratoconjunctivitis(SLK), we examined HLA-A,B,C and DR antigens in Japanese patients with SLK.

Methods: : HLA-A,B,C and DR typing was performed in 29 patients with SLK and 103 healthy controls by using microcytotoxicity test. DRB1 gene typing of DRB1*1501,1502,1601 and 1602 was also performed in 5 patients with SLK.

Results: : 1) HLA-A,B and C antigens showed no significant differences between patients with SLK and controls. 2) In HLA-DR antigens, HLA-DR2 antigen was more frequent in patients with SLK (18/29, 62.1%) than controls (34/103, 33.0%) (p<0.005 RR=3.32)3) In gene typing, all of five patients with SLK showed DRB1*1501. 4) There was no significant differences of the incidence of HLA-DR2 between SLK patients with or without Graves disease. (with Graves 9/13 69.2%, without Graves 10/16 52.5%)

Conclusions: : These results indicate that SLK may be associated with genes in the HLA-DR region and that genetic factors linked to HLA play a role in the pathogenesis of this disease.

Keywords: conjunctivitis • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×